Amphastar Pharmaceuticals Inc vs Nano Dimension Ltd - ADR — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Nano Dimension Ltd - ADR trades at $1.65 (market cap $350.49M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 2.5× Nano Dimension Ltd - ADR's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | NNDM | |
|---|---|---|
Market Cap | $868.62M | $350.49M |
Sector | Health | Technology |
52-Week High | $30.81 | $2.14 |
52-Week Low | $16.87 | $1.21 |
Enterprise Value | $1.27B | -$54.35M |
Trailing returns across standard periods
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →